Close

Search

Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
SPECIAL ANNOUNCEMENT
2016 Photonics Buyers' Guide Clearance! – Use Coupon Code FC16 to save 60%!
share
Email Facebook Twitter Google+ LinkedIn Comments

Hologic Inc.

BioPhotonics
May 2009
Bedford, Mass.-based Hologic Inc. has received FDA approval for two of its tests for the human papilloma virus. The company’s HPV HR (high risk) and HPV 16/18 were designed to detect the 14 high-risk types of the virus, known to cause cervical cancer, and to detect types 16 and 18, which are associated with about 70 percent of cervical cancers, respectively.


Comments
Terms & Conditions Privacy Policy About Us Contact Us
back to top

Facebook Twitter Instagram LinkedIn YouTube RSS
©2016 Photonics Media
x Subscribe to BioPhotonics magazine - FREE!